Cross Lab
Anne Cross, MD

Left to right: Rob Naismith, MD, Anne Cross, MD, Victor Song, PhD and Robyn Klein, MD
The Cross Lab at WashU Medicine is dedicated to understanding the mechanisms underlying inflammation and demyelination in the central nervous system, with a primary focus on multiple sclerosis (MS) — a common neurological disease affecting approximately 1 in 1,000 people in the United States.
Our research involves the study of human tissues, including blood, DNA, RNA and spinal fluid, as well as advanced imaging of the human nervous system. In some cases, we also use experimental autoimmune encephalomyelitis (EAE), an established animal model of MS, to explore disease mechanisms.
Current research focus
We are conducting longitudinal imaging studies aimed at distinguishing between different types of MS-related pathology, such as:
- Demyelination
- Inflammation caused by immune cells or edema from blood-brain barrier breakdown
- Axonal damage and loss
Our lab is funded to develop improved methods for measuring MS progression over time, which may be applied in future clinical trials.
Additional areas of study
We are also investigating the role of diet and calorie restriction in modulating neuroinflammation. Previous findings from our lab have shown that calorie restriction can reduce the severity of EAE, potentially through the upregulation of adiponectin and downregulation of leptin.
Principal investigator
Recent publications
- Dynamics of Spinal Fluid Immune Cell Alterations Following Cladribine Tablet Treatment in Multiple SclerosisSmirnov, R. A., Cantoni, C., Lee, K., Agnihotri, R. A., Axtell, R. C., Albright, A., Lancia, S., Paley, M. A., Hayward, B., Korich, J., Evans, E., Pardo, G., Obeidat, A. Z., Stuve, O., Bar-Or, A., Artyomov, M. N., Cross, A., Edelson, B. T. & Wu, G., May 1 2026, In: Neurology: Neuroimmunology and NeuroInflammation. 13, 3, p. e200565Research output: Contribution to journal › Article › peer-review
- From Diagnosis to Disease Staging: Multisite Validation of Cerebrospinal Fluid Molecular Tests in Multiple SclerosisGhezzi, L., Kosa, P., Greenwood, M., Alvarez, E., Freedman, C. L., Cross, A. H., Pace, F., Freedman, M. S., Kocot, J., Piccio, L. & Bielekova, B., Feb 2026, In: Annals of neurology. 99, 2, p. 328-340 13 p.Research output: Contribution to journal › Article › peer-review
- Beyond BMI: incorporating new obesity definitions to guide MS risk stratificationShirani, A. & Cross, A., Jan 2026, In: Neurological Sciences. 47, 1, 133.Research output: Contribution to journal › Letter › peer-review
- AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)—A Comprehensive Neurological Protocol From a Single MRI ScanLewis, J., Goyal, M., Wu, G., Hu, Y., Sukstanskii, A. L., Kothapalli, S. V. V. N., Cross, A., Kamilov, U. & Yablonskiy, D. A., 2026, (Accepted/In press) In: Journal of Magnetic Resonance Imaging.Research output: Contribution to journal › Article › peer-review
- Unraveling the major role of vascular (R2') contributions to R2* signal relaxation at ultra-high-field MRI: A comprehensive analysis with quantitative gradient recalled echo in mouse brainIm, J., Xiang, B., Levasseur, V. A., Sukstanskii, A. L., Quirk, J. D., Kothapalli, S. V. V. N., Cross, A. H. & Yablonskiy, D. A., Aug 2025, In: Magnetic resonance in medicine. 94, 2, p. 761-770 10 p.Research output: Contribution to journal › Article › peer-review